The pathogenesis of H9N2 subtype avian influenza virus (AIV) infection in hens is often related to oviduct tissue damage. Our previous study suggested that H9N2 AIV induces cellular apoptosis by activating reactive oxygen species (ROS) accumulation and mitochondria-mediated apoptotic signalling in chicken oviduct epithelial cells (COECs). Heme oxygenase-1 (HO-1) is an inducible enzyme that exerts protective effects against oxidative stress and activated HO-1 was recently shown to have antiviral activity. To study the potential involvement of HO-1 in H9N2 AIV proliferation, the role of its expression in H9N2-infected COECs was further investigated. Our results revealed that H9N2 AIV infection significantly up-regulated the expression of HO-1 and that HO-1 down-regulation by ZnPP, a classical inhibitor of HO-1, could inhibit H9N2 AIV replication in COECs. Similarly, the small interfering RNA (siRNA)-mediated knockdown of HO-1 also markedly decreased the virus production in H9N2-infected COECs. In contrast, adenoviral-mediated over-expression of HO-1 concomitantly promoted H9N2 AIV replication. Taken together, our study demonstrated the involvement of HO-1 in AIV H9N2 proliferation, and these findings suggested that HO-1 is a potential target for inhibition of AIV H9N2 replication.
INTRODUCTION
H9N2 subtype avian influenza virus (AIV) has been widespread in domestic poultry in Asian countries since the mid-1990s, with a mortality rate ranging from 5 to 30 %. H9N2 AIV was classified as a low-pathogenicity avian influenza (LPAI) based on molecular characterization and pathotyping [1] . It is known that the apoptosis and hyperinduction of the inflammatory cytokines caused by AIV in the respiratory and digestive tracts are the major causes of respiratory and digestive failure, respectively [2, 3] . Although extensive efforts have been made to understand the influenza virus infection in mammalian species, little is known about AIV infection in the oviducts of egg-laying hens. Our previous study identified that the oviducts are one of the potential targets for the H9N2 virus [4] , and that egg-laying hens experimentally infected with H9N2 AIV showed reduced egg quality and up-regulation of inflammatory cytokine genes in the oviduct tissue [5, 6] . It is interested to note that H9N2 AIV infection can induce cellular apoptosis by activating reactive oxygen species (ROS) accumulation and mitochondria-mediated apoptotic signalling in chicken oviduct epithelial cells (COECs) [7] .
Heme oxygenase-1 (HO-1) is an inducible enzyme that exerts pronounced antioxidant and anti-inflammatory effects [8, 9] . HO-1 degrades heme to produce biliverdin, carbon monoxide (CO) and ferrous iron (Fe 3+ ), which function as potential cytoprotectants [10, 11] . A growing body of evidence has demonstrated the significant anti-viral properties of HO-1. Specifically, up-regulation of HO-1 was shown to suppress infection by porcine reproductive and respiratory syndrome virus (PRRSV), hepatitis B virus (HBV) and ebola virus (EBOV) [12] [13] [14] . In contrast, infection with H1N1 subtype influenza virus significantly increased the expression of HO-1 in the lungs of infected mice and inhibition of HO-1 expression did not alter virusinduced mortality [15] . However, the effect of HO-1 induction on H9N2 AIV infection in avian-derived cells is unknown. The present study aimed to investigate the involvement of HO-1 protein in H9N2 AIV proliferation in primary chicken oviduct epithelial cells. (Fig. 1a) . In particular, the infected cells at 48 h p.i. displayed robust CPE, including rounding, blebbing, membrane fusion, clumping, ballooning and detachment. No such changes were observed in mock-infected cells. Furthermore, Fig. 1(b) shows that viral production increased in COECs in an infection time-dependent manner. To determine the effect of H9N2 AIV infection on the expression of HO-1, the changes of HO-1 expression levels in H9N2 AIV-infected COECs were assessed by quantitative RT-PCR and Western blot analysis. As shown in Fig. 1 (c-e), both the mRNA and protein expression of HO-1 in H9N2-infected cells increased in an infection time-dependent manner. By 48 h p.i., the mRNA and protein expression of HO-1 increased by 2.9 and 1.8-fold, respectively, compared with that at 12 h p.i. However, no significant changes in HO-1 expression were detected in mock-infected groups throughout the experiment.
Inhibition of HO-1 with ZnPP prevents H9N2 AIV replication in COECs
To determine whether HO-1 plays a potential role in H9N2 AIV replication, COECs inoculated with H9N2 AIV were treated with different concentrations of ZnPP, a classical inhibitor of HO-1, and HO-1 expression and virus replication were assessed by Western blot analysis. Decreased basal levels of HO-1 protein in mock-infected COECs treated with ZnPP compared to untreated cells confirmed the direct effect of ZnPP on the expression of HO-1 (Fig. 2a) . For H9N2 AIV-infected COECs, treatment with 40-120 µM ZnPP resulted in a dose-dependent decrease of the abundance of NS1 protein (Fig. 2b) and HO-1 protein (Fig. 2b) , and a 0.3 log 10 to 2.8 log 10 reduction in virus progeny titres (Fig. 2c ) compared with those for the untreated controls. As shown in Fig. 2(b) , the dose-dependent decrease (0.2-3-fold) in the amount of NS1 protein was parallel with a 0.1-4-fold reduction in the abundance of HO-1 protein. Furthermore, viability assays confirmed that treatment with ZnPP at the indicated concentration has no significant cytotoxic effects on COECs (Fig. 2d ).
To further confirm the effect of HO-1 inhibition on the replication of H9N2 AIV, COECs were treated with 80 µM of ZnPP for 12 h prior to H9N2 virus infection, and then viral production and HO-1 expression were examined at the indicated time points post-infection. As expected, (Fig. 3a) and NS1 protein levels (Fig. 3b, c ) compared with those for the untreated control. Similar results were observed for HO-1 protein expression. Pretreatment of COECs with ZnPP resulted in significantly inhibited HO-1 expression (by 1.2-4.6-fold) compared with that for the untreated control, while the untreated controls showed gradually increased expression of HO-1 with time post-infection ( Fig. 3b, d ). To rule out the possibility that ZnPP is acting directly on the influenza virus to inhibit its replication rather than via HO-1 expression level modulation, COECs were transfected with an siRNA targeting HO-1 for 24 h followed by treatment with ZnPP and infection with H9N2 AIV. Small interfering RNA-mediated knockdown of HO-1 was verified by Western blot analysis. As shown in Fig. 3 (e, f), the expression of HO-1 in COECs transfected with siRNA targeting HO-1 at concentrations of 50 or 100 nM decreased by up to almost 2.3-fold compared with that for the control transfected with the scrambled nonspecific siRNA. Treatment with different concentrations of ZnPP led to a dose-dependent decrease of NS1 protein expression in the nonspecific siRNA controls, while markedly reduced NS1 levels or levels showing no significant difference were detected in siRNA HO-1-transfected cells among the indicated concentrations of ZnPP (Fig. 3g,  h ). Together, these data demonstrate that ZnPP downregulates HO-1 expression and inhibits H9N2 AIV replication in COECs without affecting cell viability.
Knock-down of HO-1 by siRNA inhibits H9N2 AIV replication in COECs
To further confirm that the attenuation of H9N2 AIV replication by ZnPP is dependent upon HO-1 inhibition, the effect of HO-1 knockdown by siRNA on viral replication in COECs infected with H9N2 AIV was analysed. Pretreatment with siRNA targeted to the HO-1 significantly decreased virus titres by 1.2-2.6 log 10 ( Fig. 4a) , and the abundance of NS1 protein by 0.3-1.8-fold (Fig. 4b, c ) compared with those for the nonspecific siRNA control. A similar pattern of HO-1 protein expression was also detected in transfected COECs. As shown in Fig. 4 (b, d), HO-1 expression in siRNA HO-1-transfected cells decreased by 1.6-2.2-fold compared with that for nonspecific siRNA control at the same time point post-infection.
Over-expression of HO-1 promotes H9N2 AIV replication in COECs
Because inhibition of HO-1 by ZnPP or siRNA knockdown inhibited H9N2 AIV replication, it is important to define whether increased basal levels of HO-1 have an impact on H9N2 AIV replication. A recombinant adenovirus (Adv) that over-expressed HO-1 was used to increase the abundance of HO-1. COECs were infected with either AdvVector or Adv-HO-1 for 24 h, and then infected with H9N2 AIV. As shown in Fig. 5 , adenovirus-mediated HO-1 overexpression significantly increased virus titres by 1.25 log 10 ( Fig. 5a) , and the abundance of NS1 protein by 0.3-1.1-fold (Fig. 5b, c) . Furthermore, the expression levels of HO-1 in the cells co-infected with the Adv-HO-1 and H9N2 AIV were increased by 1.2-2.3-fold in comparison with those for the cells co-infected with Adv-Vector control and H9N2 AIV (Fig. 5b, d ).
DISCUSSION
HO-1 possesses antioxidant and anti-inflammatory properties, protecting tissues and organs from septic shock, virusinduced oxidative injury and haemorrhage-induced hypoxia [8] . Previous studies have indicated the ability of virus to modulate the levels of HO-1 in vitro and in vivo, and different viruses produced different HO-1 regulation [12] [13] [14] [15] . However, the expression of HO-1 in response to H9N2 AIV infection and the role of HO-1 in H9N2 AIV infection are not clear. The present study clearly showed that H9N2 AIV infection markedly increases the expression of HO-1 in COECs. Furthermore, treatment of COECs with HO-1 inhibitor ZnPP or prior application of siRNA targeting HO-1 knockdown significantly decreases H9N2 AIV replication, while adenovirus-mediated HO-1 over-expression promotes virus replication in COECs.
Indeed, there is increasing evidence to suggest that the host cell oxidative stress status plays an important role in regulating viral replication and infection [12] [13] [14] [15] . Significantly, many reports have shown that the expression of HO-1 is usually regulated by viral infection, while the levels of HO-1 expression also regulate viral replication [12] [13] [14] . Overexpression or induction of HO-1 may reduce pro-oxidant levels and increase cellular resistance to oxidant-induced cytotoxicity, thereby protecting against cell death and the apoptosis triggered by oxidative stress conditions. Our previous studies demonstrated that H9N2 AIV infection can induce oxidative stress-mediated apoptosis in COECs via its nonstructural NS1 protein [7] . We can combine this with the data obtained in this study that showed that H9N2 virus infection induced up-regulation of HO-1 in a infection time-dependent manner, and indicated that H9N2 AIV infection can induce cellular oxidative stress in the host cell and activate the HO-1 pathway to relieve oxidative stress and establish persistent viral shedding.
Although our data demonstrated that H9N2 AIV infection induces the expression of HO-1 in avian-derived cells, it is not clear whether HO-1 plays an anti-or pro-viral role in H9N2 AIV infection. Zinc protoporphyrin (ZnPP) is an endogenous heme analogue that competitively inhibits heme oxygenase (HO) activity [16] . ZnPP also regulates the expression of HO-1 at the transcriptional level and was identified as a classical inhibitor of HO-1 [17] . To determine whether the suppression of HO-1 regulates H9N2 AIV replication, the effects of ZnPP-mediated inhibition of HO-1 expression on virus replication were investigated. Pretreatment of COECs with ZnPP reduced HO-1 expression and concomitantly decreased the levels of H9N2 AIV replication and progeny virus production. Analysis of cell viability showed that down-regulation of HO-1 had no influence on cell viability, which suggests that the inhibition of H9N2 replication in ZnPP-treated COECs, therefore, appears to be due to down-regulation of HO-1 rather than reduced cell viability. Furthermore, the fact that HO-1 knockdown by siRNA inhibited H9N2 replication in COECs suggested a direct correlation between HO-1 suppression and the inhibition of H9N2 replication. HO-1 has previously been investigated in the pathogenesis of influenza. Previous in vivo and in vitro studies have demonstrated that the activation of HO-1-mediated interferon response inhibited influenza virus replication in human and murine cells [18, 19] . However, there have been few reports that down-regulation of HO-1 inhibits viral replication, although inhibition of viral replication by up-regulation of HO-1 is a well-established observation [20] [21] [22] . Therefore, the inhibition of H9N2 replication by down-regulation of HO-1 implies a singular mechanism of interaction between H9N2 AIV and HO-1. Furthermore, the specific pro-viral effect of HO-1 induction was confirmed by recombinant adenovirus-mediated HO-1 over-expression in COECs. HO-1 induction by Adv-HO-1 promoted higher levels of H9N2 N protein expression and progeny virus production, suggesting that increased basal levels of HO-1 have an impact on H9N2 AIV replication. Although precise delineation of this requires additional studies, the present data identify HO-1 as a potential target for inhibition of H9N2 replication. Further studies are needed to determine whether the different expression of HO-1 in response to influenza virus infection is cell type-and/or virus isotype-dependent.
In conclusion, the present study demonstrated that H9N2 AIV infection induces the expression of HO-1 in COECs, and inhibition of HO-1 by ZnPP or siRNA knockdown suppresses H9N2 AIV replication in vitro. These results suggest that HO-1 inhibition is a useful prevention and treatment strategy against H9N2 AIV infection and warrant further in vivo investigation.
METHODS

Cell culture and virus infection
Primary chicken oviduct epithelial cells (COECs) were isolated as described previously [7] and cell purification was confirmed before experimentation by determining the expression of cytokeratin [7] . The cells were cultured in minimal essential medium (MEM; Thermo Fisher Scientific) supplemented with 10 % foetal bovine serum (FBS) and 2 % heat-inactivated chicken serum (HICS; Gibco, Thermo Fisher Scientific), along with insulin (0.12 U ml À1 ; Sigma-Aldrich) and estradiol (50 nM; Sigma-Aldrich) at 37 C in 5 % CO 2 . The virus strain used in this study, H9N2 subtype AIV strain (A/Chicken/shaanxi/01/2011), was isolated from diseased chicken in Shaanxi, China and propagated in 10-day-old embryonated chicken eggs (ECEs) at 37 C for 72 h as previously described [23] .
The COECs were cultured in six-well plates (3Â10 5 cells/ well) and incubated at 37 C with 5 % CO 2 . When 80-90 % confluent, the COECs were infected with H9N2 AIV (A/Chicken/shaanxi/01/2011) as previously described [7] at a multiplicity of infection (m.o.i.) of 1, or mock-infected with sterila phosphate-buffered saline (PBS). Following a 1h adsorption period, unattached viruses or PBS were removed by aspiration. The cells were then washed three times with sterile PBS and cultured in fresh MEM supplemented with 2 % FBS for various time points.
TCID 50 assay Total virus yields (intracellular and extracellular viruses) were determined by the microtitration infectivity assay, calculated using the Reed-Muench methods [24] , and recorded as TCID 50 ml
À1
. Briefly, the COECs cultivated in 96-well plates were inoculated with H9N2 AIV dilutions (100 µl/well) prepared by serial 10-fold dilution. After adsorption for 1 h at 37 C, the culture supernatants were removed and DMEM with 2 % FBS was added to the wells. The plates were harvested at indicated time points post-infection. Finally, virus titres were determined by calculating the presence of a visible CPE in the wells with different dilutions.
Cell viability assay
The cytotoxicity of ZnPP was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Beyotime, Nanjing, People's Republic of China). COECs were added to each well of 96-well plates (1Â10 4 cells well À1 ). After culturing for 24 h at 37 C in 5 % CO 2 , ZnPP was added at a specific concentration and cultured for 24 h. Then 10 µl CCK-8 reagent was added to each well of a 96-well plate containing 100 µl culture medium according to the manufacturer's instructions and incubated for 2 h at 37 C. Viable cells were evaluated by absorbance measurements at 450 nm. The results were expressed relative to the optical density of wells containing untreated control cells defined as 100 % viable.
Quantitative reverse transcriptase-PCR (qRT-PCR)
Total RNA from COEC cells or supernatant H9N2 RNA was extracted using the TRIzol reagent and reverse-transcribed using the Primescript RT reagent kit (TaKaRa, Dalian, People's Republic of China) according to the manufacturer's instructions. Quantitative PCR (qPCR) reaction was performed on the Step One Plus real-time PCR system (Applied Biosystems, Foster City, CA, USA) using FastStart Universal SYBR green master (Roche, Basel, Switzerland), and forward and reverse primers for the HO-1 and the RNA of H9N2 AIV. Beta-actin mRNA was used as an internal reference. The sequences of the primers used were as follows: Chick HO-1, 5¢-CTTCGCACAAGGAGTGTTAAC-3¢ (forward), 5¢-CATCCTGCTTGTCCTCTCAC-3¢ (reverse) b actin, 5¢-AGACATCAGGGTGTGATGGTTGGT-3¢ (forward) and 5¢-TGGTGACAATACCGTGTTCAATGG-3¢ (reverse).
Western blot analysis
Protein homogenates from the oviduct epithelial cells were extracted as previously described [25] . Briefly, the cells were lysed for 20 min on ice with lysis buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl and 1 % Triton X-100, supplemented with protease inhibitor cocktail tablets (Roche). The lysates were centrifuged at 12 000 g for 20 min at 4
C to obtain a clear lysate. The protein content of each sample was determined using the BCA protein assay kit (Thermo Scientific). Then, equal amounts of protein were separated on a 12 % SDS-polyacrylamide gel and transferred to polyvinylidene difluoride membranes. The membranes were probed overnight at 4 C with the following primary antibodies: mouse anti-AIV NS1 (1 : 500; Santa Cruz Biotechnology), mouse anti-HO-1 (1 : 1500; Abcam), or mouse anti-b actin (1 : 2500; Abcam). The bands were visualized using HRP-conjugated goat anti-mouse IgG (1 : 15 000, Boster) prior to the ECL protocol (Amersham Biosciences, Piscataway, NJ, USA). As an internal standard, all membranes stripped with primary antibodies were reprobed with anti-b-actin antibody (Invitrogen). Changes in protein expression were determined after normalizing the band intensity of each lane to that of b-actin. The signal was visualized using the Konica SRX 101A developer (Konica Minolta Medical Imaging, Wayne, NJ, USA) and Quantity One software (Bio-Rad, Mississauga, ON, Canada) was used to densitometrical analysis.
Small interfering RNA transfection
The small interfering RNA (siRNA) oligonucleotides specific for chicken hemeoxygenase 1 mRNA (GenBank accession number: 396287) were as follows: 5¢-CCTGTCTATGC TCCTGTTT-3¢. COEC monolayers were transfected with HO-1 siRNA and non-targeting control siRNA using lipofectamine 2000 (Invitrogen) in accordance with the manufacturer's protocol. Briefly, the cells (5Â10 5 cells well À1 ) seeded into a six-well plate were transfected with 100 nM of control or Fn14 siRNA (RiboBio, GuangZhou, People's Republic of China) using 5 µl of lipofectamine 2000 and 500 µl of Opti-MEMI (Invitrogen) for 6 h following the manufacturer's instructions (Invitrogen). Then, the medium of the cells was replaced with fresh medium. The cells were harvested at indicated time points post-transfection and knockdown of HO-1 expression was determined by Western blot analysis.
Production of recombinant adenoviruses
The chicken HO-1 gene was first cloned into a shuttle vector-pAdTrack-CMV (Stratagen, New York, CA, USA). The resultant plasmid was linearized with PmeI and subsequently co-transformed with the pAdEasy-1 into Escherichia coli BJ5183. Recombinants were selected for kanamycin resistance and insertion was confirmed by restriction endonuclease analysis. Recombinant adenovirus plasmids were digested with PacI and transfected into HEK-293A cells. Recombinant adenoviruses were generated in HEK-293A packaging cells within 14-20 days. To generate high-titre viral stock, the recombinant adenoviruses were harvested and passaged three times in HEK-293A and then CsCl-purified. The titres of the purified viruses were determined by limiting dilution using standard methods. These recombinant adenoviruses were designated Adv-HO-1 and AdvVector, respectively.
Statistical analysis
All data were presented as the means±SEM of at least three independent experiments. Significant differences were analysed using a two-tailed Student's t-test or one-way analysis of variance (ANOVA) accompanied by Tukey's multiple comparison test. Values of P<0.05 were considered statistically significant.
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